Young invincibles who are used to their parents' plans will no doubt want to continue coverage
The newly insured will arrive in the market with unknown histories and uncertain futures. Plans must predict their health status and health needs to determine their relative risk.
“Like anything, it is never simple,” says Don Hall, principal of consulting firm DeltaSigma LLC, and an MHE editorial advisor. He sees three populations of uninsured:
“Many of those will be young, healthy adults. We will find pockets within these populations that will have a high need, but there won’t be a lot of need in general,” says Hall.
He doesn’t believe the country will see the pent up demand that some have predicted.
“States that have seen expansions have not seen that happen,” he says. “People without a lot of money have been accessing care through federal and rural health centers. Getting insurance only means that they will be using more private providers instead of federally funded health centers.”
Utilization could run steady, except in one subpopulation of covered Americans in the Medicaid expansion-the childless adults who are not working and need treatment for behavioral health conditions. And that is a group for which no one is prepared because of the “drastic shortage of behavioral health resources in this country,” he says.
What will be crucial to the success of the exchanges is attracting the young invincibles who have above average health status as a population. In contrast, there won’t be a lot of marketing directed toward those with chronic conditions or older people, who might be expected to seek out insurance regardless of marketing messages.
“I think it was a brilliant stroke by the Obama administration to cover everyone up to 26 years old on their parents’ health plans,” says Hall. “They have been getting health insurance as adults where before they might have been uninsured, so that when they age out of the plan, the expectation is that they need health insurance. It created the demand that will feed the exchanges going forward.”
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Addressing the Challenges of AI is Imperative | AMCP Nexus 2024
October 22nd 2024There is a need for strict policies regarding the use of AI in the managed care space, according to Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy.
Read More
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Technology can help address the complexities of specialty medications by automating processes and enabling proactive interventions to ensure patients stay on their critical therapies, according to Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research.
Read More
The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024
Published: October 21st 2024 | Updated: October 21st 2024Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy complications in patients. But this could be an early worsening of disease unrelated to treatment.
Read More